|
|
| Thérapies > Etude de marché sectorielle |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Juillet 2005 |
Taille du document : |
28 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Latin American Cancer Market Outlook to 2010
173 pages | Novembre 2005 |
The patient pool for cancer therapies is rising at a higher rate than the growth rate in population across the ten Latin American pharmaceutical markets, a trend primarily driven by the rising life ex |
2 443,75 €
|
| |
| |
MarketWatch: CNS
29 pages | Octobre 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
170,00 €
|
| |
| |
Stakeholder Insight: Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
199 pages | Avril 2005 |
IntroductionAnthracycline-based regimens and tamoxifen are well-established in the treatment of early-stage breast cancer.
In recent days, however, agents such as Sanofi-Aventis's Taxotere and Astr |
9 120,00 €
|
| |
| |
MarketWatch: Cancer
29 pages | Avril 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
Stakeholder Opinions: Chronic Leukemias - Curative Intent Raises the Bar
174 pages | Octobre 2005 |
IntroductionRecognizing that prolonging disease-free survival in chronic leukemia relies on the eradication of minimal residual disease has raised the bar for developers of novel pharmacotherapy.
I |
3 230,00 €
|
| |
| |
MarketWatch: Cancer
31 pages | Janvier 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
US Antidepressants 2004
12 pages | Décembre 2004 |
Snapdata's US Antidepressants 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US antidepressant market, and |
240,00 €
|
| |
| |
Nutraceuticals - Targeting Consumers Aged 35+
154 pages | Septembre 2000 |
Not only does the 35+ consumer group account for a significant and growing percentage of the total population; it is also at the greatest risk of major illnesses.
Despite advances in medicine |
955,00 €
|
| |
| |
MarketWatch: CNS
25 pages | Février 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
The Cancer Outlook 2000
128 pages | Septembre 2000 |
Driven by the cytotoxic, adjunct and innovative drug classes, the cancer market grew by 16% in 1999 to a global value of almost $19bn, and is now poised on the verge of a period of significant exp |
955,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the
CNS industry.
|
|
In this month’s MarketWatch…
This month's highlights
Page 2 - Key Announcements
Page 2 - CNS News Round-Up
Neurology
Page 4 - Opinion
Page 5 - Headlines
Page 5 - Alzheimer's Disease Update
Page 7 - Multiple Sclerosis Update
Page 9 - Epilepsy Update
Psychiatry
Page 11 - Headlines
Page 11 - Psychosis Update
Page 12 - Other Psychiatry Update
Pain
Page 15 - Headlines
Page 15 - R&D Update
Page 17 - Regulatory Update
Company Spotlight
Page 19 - Teva Pharmaceutical Industries
Further Reading
Page 26
Index
Page 27 - Pharma companies
Page 27 - Biotech companies
Page 28 - Key Drugs
|
|
|
PPLSEN
|
|
|
|
|
